Wells Fargo’s Aligos Therapeutics ALGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.3K | Sell |
13,770
-9,260
| -40% | -$66.8K | ﹤0.01% | 4792 |
|
|
2025
Q1 | $190K | Buy |
23,030
+1,230
| +6% | +$10.1K | ﹤0.01% | 4305 |
|
|
2024
Q4 | $869K | Buy |
+21,800
| New | +$869K | ﹤0.01% | 3358 |
|
|
2024
Q2 | – | Sell |
-298
| Closed | -$292 | – | 6492 |
|
|
2024
Q1 | $292 | Buy |
298
+5
| +2% | +$5 | ﹤0.01% | 6016 |
|
|
2023
Q4 | $195 | Buy |
293
+98
| +50% | +$65 | ﹤0.01% | 6173 |
|
|
2023
Q3 | $146 | Sell |
195
-3
| -2% | -$2 | ﹤0.01% | 6284 |
|
|
2023
Q2 | $192 | Buy |
198
+22
| +13% | +$21 | ﹤0.01% | 6407 |
|
|
2023
Q1 | $154 | Buy |
176
+3
| +2% | +$3 | ﹤0.01% | 6519 |
|
|
2022
Q4 | $165 | Buy |
173
+4
| +2% | +$4 | ﹤0.01% | 6348 |
|
|
2022
Q3 | $0 | Buy |
169
+44
| +35% | – | ﹤0.01% | 6273 |
|
|
2022
Q2 | $0 | Sell |
125
-928
| -88% | – | ﹤0.01% | 6447 |
|
|
2022
Q1 | $2K | Sell |
1,053
-7,510
| -88% | -$14.3K | ﹤0.01% | 6287 |
|
|
2021
Q4 | $101K | Buy |
+8,563
| New | +$101K | ﹤0.01% | 5228 |
|
|
2021
Q2 | – | Sell |
-3,269
| Closed | -$74K | – | 6509 |
|
|
2021
Q1 | $74K | Sell |
3,269
-1,979
| -38% | -$44.8K | ﹤0.01% | 5276 |
|
|
2020
Q4 | $145K | Buy |
+5,248
| New | +$145K | ﹤0.01% | 5065 |
|